Horizon Pharma plc is no longer an independent company. Amgen completed its acquisition of Horizon Therapeutics plc in October 2023 for approximately $27.8 billion. Horizon's operations are now part of Amgen.
We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.